Clinical Trial Update: BDD With UDCA Therapy After Laparoscopic Cholecystectomy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ursodeoxycholic acid (UDCA) therapy after laparoscopic cholecystectomy for acute and chronic cholecystitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholecystitis

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Ewha Womans University Mokdong Hospital | Conditions: Cholecystitis, Acute, Cholecystitis, Chronic | Phase 3 | Status: UNKNOWN